With inflation pressures flaring again, bond yields climbing in major markets and energy shocks rippling through everything from housing to food, many investors are looking for stocks with solid finances and clear earnings growth potential. That is exactly what the Healthy high growth potential screener aims to filter for, focusing on companies that analysts expect to grow earnings strongly over the next 3 years while still meeting basic balance sheet checks. In this article, you will see 3 of the stocks from this screener, giving you a focused starting list for further research in a market where quality growth is harder to find.

Remitly Global (RELY)

Overview: Remitly Global is a Seattle based digital financial services company that enables people to send money across borders via its mobile app and website, serving customers in the United States, Canada and a wide range of international markets, with a focus on remittances and related services for migrants and their families.

Operations: Remitly generates virtually all of its US$1.7b in revenue from data processing related to its cross border remittance platform, with around US$1.1b from the United States, US$168.1m from Canada and US$414.7m from the rest of the world.

Market Cap: US$5.1b

Remitly Global stands out in this screener because it sits at the crossroads of cross border money flows, digital wallets and AI powered risk tools. Analysts expect double digit revenue and earnings growth over the next few years and highlight improving profit margins and free cash flow. Recent index inclusions into the Russell and S&P series, plus raised 2026 revenue guidance and accelerating customer growth, point to growing scale and market recognition. At the same time, a high P/E ratio, reliance on external borrowings and meaningful insider selling introduce valuation and governance questions, while stablecoin and regulatory exposure add extra complexity. Investors looking at Remitly need to weigh those growth engines against these risks and decide what the balance is worth.

Remitly Global’s accelerating customer growth and higher 2026 revenue guidance raise a simple question: does the current P/E really capture the full story, or are key risks being masked in the 2 key rewards and 1 important warning sign

Vera Therapeutics (VERA)

Overview: Vera Therapeutics is a clinical stage biotech company based in California that develops treatments for immune driven kidney and viral diseases, led by its BAFF/APRIL blocking drug atacicept for IgA nephropathy and other autoimmune kidney conditions, along with early stage programs targeting BK virus and broader B cell mediated disorders.

Market Cap: US$2.9b

Vera Therapeutics is on many growth watchlists because FDA accelerated approval for TRUTAKNA (atacicept) in IgA nephropathy gives the company a potential first commercial product. Analysts expect rapid revenue and earnings growth and a path to profitability within 3 years if forecasts hold. At the same time, Vera is still loss making with a very high return on equity deficit and virtually no reported revenue yet, and it relies heavily on higher risk external funding. The investment case now hangs on whether TRUTAKNA’s confirmatory trial data and planned filings in 2026 can support continued approval and broader use, and how that balances against valuation debates, execution risk and a concentrated product portfolio.

Vera Therapeutics sits at the point where accelerated approval hype meets funding risk and reliance on a single key drug. Before the story moves into its next phase, scan the 2 key rewards and 1 important major warning sign

Advanced Energy Industries (AEIS)

Overview: Advanced Energy Industries supplies precision power conversion, measurement and control equipment that sits at the core of semiconductor manufacturing, AI and data center infrastructure, industrial production, and medical and life science equipment. Its products help customers run complex processes reliably and efficiently.

Operations: Advanced Energy Industries generates about US$1.9b in revenue from its Power Electronics Conversion Products segment, serving customers across Mexico, the United States and other international markets.

Market Cap: US$11.8b

Advanced Energy Industries is drawing attention because it sits directly in the AI and semiconductor build out. Analysts expect earnings to grow faster than revenue as the company focuses on higher margin power platforms for data centers and wafer fabs, and supports this with buybacks and R&D. Rising profitability, high earnings quality and expectations for ROE to reach the mid 20%s indicate an improving fundamental picture. Recent index inclusions and product launches in 800 V AI data center power also help broaden its customer base. The flip side is a rich valuation, reliance on external funding and exposure to a few large, cyclical customers and tariff policy, so the key question is whether the potential earnings runway is enough to compensate for those pressure points.

Advanced Energy Industries sits at the intersection of AI infrastructure demand and a rich valuation, and the real tension lies in the growth runway that analysts are modeling in the analyst forecasts for Advanced Energy Industries

The three stocks covered here are only a sample of what this idea surfaces, with the full Healthy high growth potential screen flagging 1,483 more companies that analysts see with similar earnings momentum and balance sheet strength inside the Healthy high growth potential screener. Use Simply Wall St to identify, filter and analyze the specific catalysts and narratives that matter to you, so you can focus on the opportunities you have the highest conviction in from that broader list.

Take Control of Your Investment Journey

If Advanced Energy Industries or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Alternatives Before Momentum Flies Past?

Fresh stock ideas can move from quiet to breakout fast, and once momentum is flying, ideal entry windows shrink. Scan curated themes while it matters, then act now.

• Snag potential turnaround stories early by scanning a curated mix of resilient companies through the 74 resilient stocks with low risk scores before the crowd re-prices their stability.
• Hunt for potential infrastructure winners by checking a focused set of grid modernization players using the 36 power grid technology and infrastructure stocks while they are still under the radar.
• Explore structural demand for smarter factories by reviewing hand picked automation leaders via the 29 robotics and automation stocks before sentiment and pricing change.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.